Fulgent Genetics (FLGT) Non-Current Debt (2021 - 2026)

Fulgent Genetics has disclosed Non-Current Debt across 6 years of filings, most recently posting $1.5 million for Q2 2026.

• In Q2 2026, Non-Current Debt fell 24.62% year-over-year to $1.5 million; the TTM figure through Jun 2026 stood at $1.5 million (down 24.62% YoY), while the FY2025 annual figure was $2.0 million, down 21.46% from the prior year.
• Non-Current Debt came in at $1.5 million for Q2 2026 at Fulgent Genetics, roughly flat from $1.5 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $5.6 million in Q1 2022 to a low of $1.5 million in Q1 2026.
• Average Non-Current Debt over 5 years is $3.1 million, with a median of $2.5 million recorded in 2024.
• Year-over-year, Non-Current Debt declined 7.14% in 2023 and sank 52.06% in 2024.
• Over 5 years, Non-Current Debt stood at $3.4 million in 2022, then slipped by 12.1% to $3.0 million in 2023, then decreased by 15.89% to $2.5 million in 2024, then decreased by 21.46% to $2.0 million in 2025, then declined by 24.62% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Non-Current Debt figures were $1.5 million in Q2 2026, $1.5 million in Q1 2026, and $2.0 million in Q4 2025.